Confirmed Speakers already include:
Dennis Purcell, Senior Managing Director, Aisling CapitalJohn Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals
Maggie Flanagan LeFlore, PhD., Head, R&D Ventures, AstraZeneca
Mark Chalek, Chief Business Ventures, Beth Israel Deaconess Medical Centre
Alvaro Pasuale-Leone, Prof. Neurology, Beth Israel Deaconess Medical Centre
Jesper Zeuthen, Managing Director, Biomedical Venture, BankInvest Group
Janice Bourque, Senior Vice President & Group Head - Life Sciences, Comerica Bank
David Reese, Managing Director - Healthcare Group, Cornell Capital Partners
Matt Gardella, Partner & Co-Chair, Securities & Public Companies Practice, Edwards Angell Palmer & Dodge
Al Sokol, Partner, Edwards Angell Palmer & Dodge
Doug Cole, General Partner, Flagship Ventures
Issac Kohlberg, Senior Associate Provost & Chief Technology Development Officer, Harvard University
Mason 'Skip' Irving, Managing Director, Health Advances
Christopher Mirabelli, Healthcare Ventures
Stan Yakatan, Chairman, Katan Associates
Deborah Brooks, President, Michael J. Fox Foundation for Parkinson’s Research
Jeremy Levin, Head of Strategic Alliances, Novartis Institutes for Biomedical Research
Michael Lytton, General Partner, Oxford Bioscience Partners
Peter Kash, Two River Group Holdings
Jonathan Leff, Managing Director, Warburg Pincus